Related Experiment Videos
Some behavioral effects of histamine H1-, and H2-receptor agonists in rats
Abstract:
2-Pyridylethylamine (2-PEA) and 4-methylhistamine (4-MeHI) when given intraventricularly at doses of 30 and 100 microgram had no discernible effect on spontaneous locomotor activity and did not visibly change gross behavior of rats. 4-MeHI(100 micrograms) injected to tranylcypromine-pretreated rats increased locomotor activity and induced head twitches. Locomotor activation was not antagonized by either cimetidine or metergoline but was prevented by alpha-methyl-p-tyrosine and haloperidol and reduced by phentolamine. 4-MeHI-, and histamine (HI)-induced head twitches were not antagonized by either cimetidine or metiamide but were completely abolished by metergoline and p-chlorophenylalanine. It is concluded that 4-MeHI--induced locomotor activation and both HI-, and 4-MeHI-induced head twitches are respectively catecholamine-, and serotonin-dependent phenomena. The behavioral effects of HI and HI H1-and H2-receptor agonists are discussed with regard to possible HI interactions with both catecholamine and serotonin systems in brain.
Insights
4-methylhistamine (4-MeHI) can increase rat locomotor activity and induce head twitches, suggesting interactions with brain catecholamine and serotonin systems. These effects are mediated by neurotransmitters, not histamine receptors.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Histamine (HI) plays a role in central nervous system functions.
- The specific roles of histamine and its receptor subtypes in modulating behavior are not fully elucidated.
- 4-methylhistamine (4-MeHI) is a histamine analog with potential central effects.
Purpose of the Study:
- To investigate the behavioral effects of intraventricular administration of 2-Pyridylethylamine (2-PEA) and 4-methylhistamine (4-MeHI) in rats.
- To determine the neurochemical systems involved in 4-MeHI-induced behavioral changes.
- To explore the potential interactions between histamine and catecholamine/serotonin systems in the brain.
Main Methods:
- Intraventricular administration of 2-PEA and 4-MeHI in rats.
- Pretreatment with tranylcypromine to enhance monoamine oxidase inhibition.
- Administration of pharmacological antagonists including cimetidine, metergoline, alpha-methyl-p-tyrosine, haloperidol, phentolamine, metiamide, and p-chlorophenylalanine.
- Observation and quantification of locomotor activity and head twitches.
Main Results:
- Intraventricular 2-PEA and 4-MeHI (30-100 µg) did not affect spontaneous locomotor activity or gross behavior in rats.
- 4-MeHI (100 µg) in tranylcypromine-pretreated rats significantly increased locomotor activity and induced head twitches.
- Locomotor activation by 4-MeHI was prevented by alpha-methyl-p-tyrosine and haloperidol, and reduced by phentolamine, indicating catecholamine involvement.
- Head twitches induced by 4-MeHI and histamine were abolished by metergoline and p-chlorophenylalanine, indicating serotonin involvement.
Conclusions:
- 4-MeHI-induced locomotor activation is dependent on the catecholamine system.
- Histamine and 4-MeHI-induced head twitches are serotonin-dependent phenomena.
- These findings suggest complex interactions between histamine, catecholamine, and serotonin systems in the brain, influencing specific behavioral outputs.